| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $113.35 | $25.92 | 337.28% | 213.87x | 53.95x | 14.38x | 17.36x | 1.55x | $106.92M | 0.90% | $705.78M | 6.70 | $12.15B | 1,548.93 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.97 | $8.82 | 171.88% | 114.14x | 55.74x | 6.74x | 13.66x | 0.98x | $39.15M | 1.25% | $220.58M | 1.69 | $3.09B | 68.13 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.63 | $18.67 | 321.05% | 73.49x | 67.27x | 7.25x | 9.38x | 1.88x | $182.84M | 3.00% | $654.15M | 8.43 | $5.97B | 49.75 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $240.69 | $85.49 | 181.54% | 39.46x | 35.48x | 6.69x | 23.78x | 1.39x | $793.95M | 2.47% | $1.35B | 10.14 | $33.49B | 28.39 | ||
| VCEL | VERICEL CORP | $39.90 | $8.62 | 362.85% | 83.13x | 71.29x | 6.65x | 5.52x | 2.04x | $61.66M | 3.03% | $370.04M | 7.25 | $2.01B | 45.64 | ||
| RPRX | ROYALTY PHARMA PLC | $61.41 | $38.83 | 58.16% | 32.66x | 11.47x | 10.78x | 3.61x | 0.66x | $2.92B | 10.70% | $9.79B | 21.99 | $43.46B | 36.95 | ||
| KRYS | KRYSTAL BIOTECH INC | $359.36 | $90.89 | 295.40% | 43.45x | 46.04x | 24.09x | 7.83x | 2.31x | $257.78M | 2.43% | $1.36B | 46.03 | $10.22B | 43.80 | ||
| HALO | HALOZYME THERAPEUTICS INC | $106.49 | $73.21 | 45.46% | 29.91x | 11.79x | 7.51x | 84.20x | 0.61x | $806.22M | 6.46% | $143.54M | 1.22 | $14.07B | 19.58 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.23 | $20.31 | 221.19% | 171.66x | 22.40x | 3.70x | 2.00x | 1.13x | $738.18M | 5.85% | $6.32B | 32.68 | $15.94B | 41.33 | ||
| TGTX | TG THERAPEUTICS INC | $54.30 | $24.17 | 124.62% | 17.63x | 54.64x | 9.63x | 13.76x | 1.96x | $17.39M | 0.23% | $604.08M | 4.26 | $8.58B | 61.63 | ||
| TECH | BIO-TECHNE CORP | $72.31 | $17.67 | 309.30% | 61.80x | 34.63x | 9.28x | 5.38x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.36B | 32.69 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.74 | $8.21 | 43.06% | 12.36x | 10.79x | 5.10x | 3.20x | 1.08x | $82.01M | 11.81% | $217.65M | 3.68 | $553.34M | 7.16 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.41 | -80.96% | 8.71x | -4.12x | 1.50x | 1.61x | 0.07x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| EXEL | EXELIXIS INC | $54.64 | $32.31 | 69.12% | 16.61x | 16.55x | 5.63x | 7.34x | 1.09x | $1.17B | 8.56% | $1.84B | 7.35 | $13.42B | 12.34 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $284.10 | $92.66 | 206.60% | 28.21x | 30.07x | 19.62x | 5.85x | 2.13x | $130.62M | 2.29% | $967.52M | 48.22 | $5.79B | 20.75 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $250.68 | $191.93 | 30.61% | 16.43x | 9.81x | 3.44x | 3.39x | 0.69x | $1.62B | 10.22% | $4.80B | 75.98 | $19.05B | 11.78 | ||
| ADMA | ADMA BIOLOGICS INC | $9.39 | $7.52 | 24.80% | 13.04x | 11.80x | 4.18x | 5.15x | 0.76x | $116.47M | 5.43% | $408.21M | 1.79 | $2.16B | 9.29 | ||
| MDXG | MIMEDX GROUP INC | $4.54 | $1.54 | 195.39% | 113.50x | -32.36x | 1.89x | 3.06x | 1.08x | $44.50M | 6.63% | $216.00M | 1.46 | $543.12M | 23.81 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $544.52 | $164.09 | 231.84% | 31.42x | 28.33x | 10.97x | 6.82x | 2.23x | $3.80B | 2.75% | $20.25B | 79.81 | $133.85B | 24.32 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $799.08 | $459.97 | 73.73% | 19.05x | 14.32x | 5.29x | 2.59x | 1.01x | $3.76B | 4.58% | $31.71B | 308.48 | $82.52B | 14.35 | ||
| UTHR | UNITED THERAPEUTICS CORP | $510.38 | $206.57 | 147.07% | 16.88x | 19.05x | 6.89x | 3.42x | 2.92x | $1.09B | 5.03% | $6.40B | 150.24 | $20.09B | 11.98 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.38 | $32.45 | 21.36% | 12.54x | 9.45x | 2.38x | 2.30x | 0.75x | $354.90M | 15.56% | $999.24M | 17.25 | $1.90B | 6.78 | ||
| INCY | INCYTE CORP | $123.22 | $63.52 | 93.99% | 15.17x | 34.76x | 4.24x | 3.94x | 1.71x | $1.92B | 7.78% | $6.34B | 31.66 | $21.02B | 10.17 | ||
| VCYT | VERACYTE INC | $43.19 | $7.30 | 491.51% | 29.99x | 41.31x | 6.15x | 2.50x | 119.30x | $165.99M | 4.81% | $1.39B | 17.36 | $3.21B | 22.99 |